MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Hair Glucocorticoids and Functional Movement Disorders Insights from a Cross Sectional Study

    VI. Lopez-Diaz, CA. Diaz-Garza, D. León Rojas, F. Luna-Rangel, M. González-González, J. Rodriguez-de-Ita, F. Castorena Torres, D. Martínez-Ramírez (Monterrey, Mexico)

    Objective: To compare hair glucocorticoid levels between patients with Functional Movement Disorders (FMD) and healthy controls. Background: FMD are complex neurological conditions that lack specific…
  • 2025 International Congress

    Severe Anti-NMDAR Encephalitis After the Covid 19 Cross-vaccination in three young women

    K. Methawasin, P. Tungkiatsilp, C. Suthamdireklap, M. Jaisa-Aad (Nakhon Nayok, Thailand)

    Objective: To describe three severe cases of anti-NMDAR encephalitis in young females after the COVID-19 cross-vaccination. Background: Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is the most recognized…
  • 2025 International Congress

    Neuroprotective Effects of Co-Administered Hesperetin and Resveratrol Nanoparticles on Oxidative Stress and Neurobehavioral Deficits in Parkinson’s Disease

    R. Rajput, S. Verma (Agra, India)

    Objective: This study aimed to evaluate the therapeutic potential of solid lipid nanoparticles (SLNs) containing hesperetin (HE-SLN), resveratrol (RE-SLN), and their co-administration (HE-RE-SLN) in combating…
  • 2025 International Congress

    Repeated Scanning Ultrasound in an Alpha-synuclein Preformed Fibril model

    V. Purrer, K. Roffey, G. Richter-Stretton, J. Song, G. Leinenga, L. Chen, E. Albornoz Balmaceda, J. Götz (St Lucia, Australia)

    Objective: To investigate the therapeutic potential of repeated scanning ultrasound (SUS)-mediated blood-brain barrier (BBB) opening in a mouse model of Parkinson’s disease (PD). Background: PD…
  • 2025 International Congress

    Impact 360 Study for Parkinson’s Disease – a controlled phase II feasibility and safety study of a combined exercise, diet and mindfulness intervention

    J. Kelly, M. Powell, R. Cloke, J. Yu, S. Stelling, T. Watson, A. Hashimoto, A. Kuan, M. Sacheli, Y. Wang, D. Darabi, S. Appel-Cresswell (Vancouver, Canada)

    Objective: The aim of this phase II controlled trial is to evaluate the safety, feasibility, and to explore the effects of a multimodal intervention in…
  • 2025 International Congress

    Utility of Digital Olfactory Assessment (Sensify) in Parkinson’s Disease: Preliminary Findings from the IPDGC Africa in Egypt

    N. Shebl, S. Mondal, F. Waheed, A. Farag, N. Abonar, M. Abdelhady, S. Asran, M. Salama, M. Rizig (Cairo, Egypt)

    Objective: Validate a digital olfactory assessment for Parkinson’s disease (PD) in Egyptian participants by comparing olfactory performance in PD patients, healthy controls, and those with…
  • 2025 International Congress

    End-of-life care management in Parkinson’s disease: a nationwide survey of French healthcare practitioners’ experiences and perceptions

    A. Lagarde, A. Camm Chapel, T. Cognard, M. Auffret (Paris, France)

    Objective: To describe the personal experiences and perceptions of healthcare practitioners (HCP) involved in the terminal management of people diagnosed with Parkinson's disease (PD) Background:…
  • 2025 International Congress

    Clinician Advisory Community: Guiding The Michael J. Fox Foundation’s Mission Through Front-Line Intelligence

    R. Dolhun, D. Kumbroch, K. Klapper, K. Wu, L. Holding, K. Callahan (New York, USA)

    Objective: Create a survey-ready community of U.S.-based clinicians to share care-focused inputs that inform The Michael J. Fox Foundation’s (MJFF) research funding and recruitment, policy,…
  • 2025 International Congress

    PHIT-Brain Study Protocol: Adaptation and Evaluation of a Multifaceted Brain Health Intervention for Patients with Parkinson’s Disease and Mild Cognitive Impairment (PD-MCI)

    G. Roth, D. Gonzalez (Chicago, USA)

    Objective: The aim is to adapt a brain health program for the PD population, the Parkinson’s Health Initiative for Thinking and the Brain (PHIT Brain),…
  • 2025 International Congress

    Impact of Cognition on Social Engagement in Community-based Older Adults with Parkinsonism

    M. Roy, Md, D. Gonzalez, Phd, M. Tosin, Phd, C. Goetz, Md, R. Wilson, Phd (Chicago, USA)

    Objective: To investigate how cognition and gait influence social engagement in parkinsonism. Background: Social engagement is vital to quality of life in parkinsonism, yet the…
  • « Previous Page
  • 1
  • …
  • 116
  • 117
  • 118
  • 119
  • 120
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • #25179 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley